SEC Form 4 · accession 0000899243-18-022801
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William F Doyle
Officer — Executive Chairman · Director
Period of report
Aug 2, 2018
Accepted (ET)
Aug 20, 2018 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Aug 2, 2018 | J | 187,787 | $0.00 | D | 438,167 | I | WFD-GP II, LLC |
| Ordinary Shares | holding | — | — | — | 912,143 | D | ||
| Ordinary SharesF2 | holding | — | — | — | 43,000 | I | WFD Ventures Fund II, L.P. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On August 2, 2018, WFD-GP II LLC distributed to certain of its economic members 187,787 of the Issuer's shares. None of the shares were distributed to Mr. Doyle.
- F2Mr. Doyle is the Managing Director of WFD Ventures LLC, the sole member of WFD-GP II LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.